Browse our anti-MDM2 (MDM2) Antibodies

Full name:
anti-Mdm2, p53 E3 Ubiquitin Protein Ligase Homolog (Mouse) Antibodies (MDM2)
On are 392 Mdm2, p53 E3 Ubiquitin Protein Ligase Homolog (Mouse) (MDM2) Antibodies from 26 different suppliers available. Additionally we are shipping MDM2 Proteins (21) and MDM2 Kits (10) and many more products for this protein. A total of 459 MDM2 products are currently listed.
1700007J15Rik, AA415488, ACTFS, hdm2, HDMX, Mdm-2, zgc:109834
list all antibodies Gene Name GeneID UniProt
MDM2 4193 Q00987
MDM2 314856  
MDM2 17246 P23804

Show all species

Show all synonyms

All available anti-MDM2 Antibodies

Go to our pre-filtered search.

Top referenced anti-MDM2 Antibodies

  1. Human Polyclonal MDM2 Primary Antibody for EIA - ABIN358421 : Burch, Scott, Pohler, Meek, Hupp: Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1. in Journal of molecular biology 2004 (PubMed)
    Show all 5 references for 358421

  2. Human Polyclonal MDM2 Primary Antibody for EIA, IHC (p) - ABIN356776 : Schon, Friedler, Freund, Fersht: Binding of p53-derived ligands to MDM2 induces a variety of long range conformational changes. in Journal of molecular biology 2004 (PubMed)
    Show all 5 references for 356776

  3. Human Polyclonal MDM2 Primary Antibody for DB, EIA - ABIN358505 : Balass, Kalef, Maya, Wilder, Oren, Katchalski-Katzir: Characterization of two peptide epitopes on Mdm2 oncoprotein that affect p53 degradation. in Peptides 2002 (PubMed)
    Show all 3 references for 358505

  4. Human Monoclonal MDM2 Primary Antibody for IHC (fro), IHC (p) - ABIN180331 : Gueven, Becherel, Birrell, Chen, DelSal, Carney, Grattan-Smith, Lavin: Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype. in Cancer research 2006 (PubMed)
    Show all 3 references for 180331

  5. Human Polyclonal MDM2 Primary Antibody for IHC (p), WB - ABIN388068 : Xia, Paik, Li: p53 activation in chronic radiation-treated breast cancer cells: regulation of MDM2/p14ARF. in Cancer research 2004 (PubMed)
    Show all 3 references for 388068

  6. Human Monoclonal MDM2 Primary Antibody for BI, IHC (f) - ABIN967511 : Martin, Trouche, Hagemeier, Sørensen, La Thangue, Kouzarides: Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. in Nature 1995 (PubMed)
    Show all 2 references for 967511

  7. Human Polyclonal MDM2 Primary Antibody for IF, IHC (p) - ABIN388067 : Lei, Velez, Kazlauskas: Pathological signaling via platelet-derived growth factor receptor {alpha} involves chronic activation of Akt and suppression of p53. in Molecular and cellular biology 2011 (PubMed)
    Show all 2 references for 388067

  8. Human Polyclonal MDM2 Primary Antibody for ELISA, WB - ABIN185508 : Bond, Hu, Bond, Robins, Lutzker, Arva, Bargonetti, Bartel, Taubert, Wuerl, Onel, Yip, Hwang, Strong, Lozano, Levine: A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. in Cell 2004 (PubMed)

More Antibodies against MDM2 Interaction Partners

Human Mdm2, p53 E3 Ubiquitin Protein Ligase Homolog (Mouse) (MDM2) interaction partners

  1. a novel molecular mechanism which, in silico, is capable of triggering p53 (show TP53 Antibodies) oscillations. The mechanism that is based on Mdm2's dual regulation of p53 (show TP53 Antibodies) can provide mechanistic insights into an excitability of the p53 (show TP53 Antibodies) network, thus it contributes to understanding of variability of p53 (show TP53 Antibodies) dynamics in response to single and double strand breaks.

  2. Histologically low-grade and relatively low-grade cases of extraskeletal osteosarcoma are not always associated with MDM2 amplification. ESOS cases with MDM2 amplification could be high grade.

  3. Disturbed p53 (show TP53 Antibodies)-MDM2 feedback loop contributing to the pathogenesis of thoracic aortic dissection may be linked to TRIM25 (show TRIM25 Antibodies) overexpression.

  4. These results identify a novel function for FKBP12 (show FKBP1A PLURAL_@30317@) in downregulating MDM2, which directly enhances sensitivity of cancer cells to chemotherapy and nutlin-3 treatment.

  5. Although uncommon, MDM2 labeling is seen in a subset of fat-predominant angiolipomas and is a potential diagnostic pitfall in the evaluation of fatty tumors of the retroperitoneum.

  6. high-level MDM2 expression is needed in order to perform a critical p53 (show TP53 Antibodies)-independent function and may obviate the need for genomic alterations to the p53 (show TP53 Antibodies) pathway during retinoblastoma tumorigenesis.

  7. p16 (show CDKN2A Antibodies) in combination with MDM2 and CDK4 (show CDK4 Antibodies) immunohistochemistry may help in the differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma.

  8. MDM2 gene single nucleotide polymorphism are associated with apoptotic signaling and smoking-related emphysematous changes in lungs.

  9. we determined the molecular mechanism responsible for IER3 (show IER3 Antibodies) degradation, involving a ternary complex of IER3 (show IER3 Antibodies), MDM2 and FHL2 (show FHL2 Antibodies), which may contribute to cervical tumor growth. Furthermore, we demonstrated that FHL2 (show FHL2 Antibodies) serves as a scaffold for E3 ligase and its substrate during the ubiquitination reaction, a function that has not been previously reported for this protein

  10. NPM1 (show NPM1 Antibodies) downregulation by P-STAT5 (show STAT5A Antibodies) is mediated by impairing the BRCA1-BARD1 (show BARD1 Antibodies) ubiquitin ligase, which controls the stability of NPM1 (show NPM1 Antibodies). In turn, decreased NPM1 (show NPM1 Antibodies) levels led to suppression of p53 (show TP53 Antibodies) expression, resulting in enhanced cell survival.

Cow (Bovine) Mdm2, p53 E3 Ubiquitin Protein Ligase Homolog (Mouse) (MDM2) interaction partners

  1. results suggest overexpression of MDM2 is closely linked to inhibition of p53 (show TP53 Antibodies)-dependent apoptosis of Theileria parva (show PARVA Antibodies)-infected lymphocytes; aberrant expression of host lymphocyte MDM2 induced by cytoplasmic existence of T. parva (show PARVA Antibodies), directly and/or indirectly, is associated with aspects of this type of transformation of T. parva (show PARVA Antibodies)-infected lymphocytes

Zebrafish Mdm2, p53 E3 Ubiquitin Protein Ligase Homolog (Mouse) (MDM2) interaction partners

  1. Data indicate that knockdown of the Mdm2 and Mdm4 (show MDM4 Antibodies) caused dramatic accumulation of mutant p53 protein (show TP53 Antibodies).

  2. Together with p53 (show TP53 Antibodies), provides an experimental model for characterizing drugs and genes that affect p53 (show TP53 Antibodies) signaling.

  3. Data show that liver-specific expression of p53 (show TP53 Antibodies)-negative regulator mdm2 leads to growth retardation and fragile liver in zebrafish.

Mouse (Murine) Mdm2, p53 E3 Ubiquitin Protein Ligase Homolog (Mouse) (MDM2) interaction partners

  1. In Fmr1 (show FMR1 Antibodies) KO neurons, Mdm2 is hyperphosphorylated, nuclear localized basally, and unaffected by MEF2 (show MEF2C Antibodies) activation, which our data suggest due to an enhanced interaction with Eukaryotic Elongation Factor (show TSFM Antibodies) 1alpha (EF1alpha), whose protein levels are elevated in Fmr1 (show FMR1 Antibodies) KO. Expression of a dephosphomimetic of Mdm2 rescues PSD-95 (show DLG4 Antibodies) ubiquitination, degradation and synapse elimination in Fmr1 (show FMR1 Antibodies) KO neurons.

  2. MDM2 is a non-redundant survival factor for proximal tubular cells by protecting them from spontaneous p53 (show TP53 Antibodies) overexpression-related cell death.

  3. The case emphasizes that MDM2 expression represents a possible pitfall in the diagnosis of spindle cell tumors. The differential diagnostic distinction between FDCS and a dedifferentiated liposarcoma is discussed.

  4. MDM2 is involved in fibroblast activation, mediating renal tubulointerstitial fibrosis via a p53 (show TP53 Antibodies)-independent pathway dependant on Notch1 (show NOTCH1 Antibodies) ubiquitination and proteasome degradation.

  5. These findings suggest that Mdm2 splice isoforms may play critical roles in the regulatory loop of p53 (show TP53 Antibodies)/Mdm2-Mdm4 (show MDM4 Antibodies) via a RING domain-mediated biochemical mechanism.

  6. both MDM2 and MDMX (show MDM4 Antibodies) deletion-caused pancreatic defects are completely rescued by loss of p53 (show TP53 Antibodies), verifying the crucial role of the MDM2 and/or MDMX (show MDM4 Antibodies) in regulating p53 (show TP53 Antibodies) in a spatio-temporal manner during the development, functional maintenance, and related disease progress of endocrine pancreas.

  7. Vif (show BTG1 Antibodies) stabilization by CBFbeta (show CBFB Antibodies) is mainly caused by impairing MDM2-mediated degradation.

  8. These results demonstrated a critical prosurvival role for MDM2 in the oocytes

  9. we failed to detect any increase in p53 (show TP53 Antibodies) level in mutant oocytes, nor any other apoptotic marker, introgression of this targeted invalidation in p53 (show TP53 Antibodies)-/- mice restored the fertility of females. This study is the first to show that Mdm2, but not Mdm4 (show MDM4 Antibodies), has a critical role in oocyte survival and would be involved in premature ovarian insufficiency phenotype.

  10. Inhibition of MDM2 re-sensitizes rapamycin resistant renal cancer cells via the activation of p53 (show TP53 Antibodies).

MDM2 Antigen Profile

Antigen Summary

This gene is a target gene of the transcription factor tumor protein p53. The encoded protein is a nuclear phosphoprotein that binds and inhibits transactivation by tumor protein p53, as part of an autoregulatory negative feedback loop. Overexpression of this gene can result in excessive inactivation of tumor protein p53, diminishing its tumor suppressor function. This protein has E3 ubiquitin ligase activity, which targets tumor protein p53 for proteasomal degradation. This protein also affects the cell cycle, apoptosis, and tumorigenesis through interactions with other proteins, including retinoblastoma 1 and ribosomal protein L5. More than 40 different alternatively spliced transcript variants have been isolated from both tumor and normal tissues.

Alternative names and synonyms associated with MDM2

  • MDM2 oncogene, E3 ubiquitin protein ligase (MDM2) antibody
  • MDM2 oncogene, E3 ubiquitin protein ligase (mdm2) antibody
  • MDM2 oncogene, E3 ubiquitin protein ligase (Mdm2) antibody
  • Mdm2, p53 E3 ubiquitin protein ligase homolog (mouse) (MDM2) antibody
  • p53 E3 ubiquitin protein ligase (Mdm2) antibody
  • transformed 3T3 cell double minute 2 homolog (mouse) (mdm2) antibody
  • transformed mouse 3T3 cell double minute 2 (Mdm2) antibody
  • 1700007J15Rik antibody
  • AA415488 antibody
  • ACTFS antibody
  • hdm2 antibody
  • HDMX antibody
  • Mdm-2 antibody
  • zgc:109834 antibody

Protein level used designations for MDM2

E3 ubiquitin-protein ligase Mdm2 , Mdm2, p53 E3 ubiquitin protein ligase homolog , Mdm2, transformed 3T3 cell double minute 2, p53 binding protein , double minute 2, human homolog of; p53-binding protein , oncoprotein Mdm2 , Mdm2 p53 binding protein homolog , double minute 2 protein , p53-binding protein Mdm2 , xdm2 , MDM2 alpha , cdm2 , double minute 2 homolog , double minute 2 , MDM2-like protein , edm2 , transformed mouse 3T3 cell double minute 2 , etID309863.4 , murine double minute 2 homolog

4193 Homo sapiens
444499 Xenopus laevis
100724684 Cavia porcellus
403693 Canis lupus familiaris
493939 Felis catus
100125959 Sus scrofa
540378 Bos taurus
100033891 Equus caballus
395609 Gallus gallus
742141 Pan troglodytes
314856 Rattus norvegicus
30637 Danio rerio
17246 Mus musculus
Selected quality suppliers for anti-MDM2 (MDM2) Antibodies
Did you look for something else?